Compugen Ltd
NASDAQ:CGEN
Compugen Ltd
NASDAQ:CGEN
Price:
2.11 USD
-2.31%
Market Closed
Updated:
May 5, 2024
Compugen Ltd
Cash from Financing Activities
|
Compugen Ltd
Cash from Financing Activities Peer Comparison
Comparables:
Q
QNRX
B
BOLT
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Compugen Ltd
NASDAQ:CGEN
|
Cash from Financing Activities
$1.4m
|
CAGR 3-Years
-63%
|
CAGR 5-Years
-46%
|
CAGR 10-Years
-27%
|
|
Q
|
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
|
Cash from Financing Activities
$5.2m
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
B
|
Biolight Life Sciences Ltd
TASE:BOLT
|
Cash from Financing Activities
₪3.3m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
-12%
|
See Also
What is Compugen Ltd's Cash from Financing Activities?
Cash from Financing Activities
1.4m
USD
1.4m
USD
Based on the financial report for Dec 31, 2023, Compugen Ltd's Cash from Financing Activities amounts to 1.4m USD.
What is Compugen Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-27%
-27%
Over the last year, the Cash from Financing Activities growth was 286%. The average annual Cash from Financing Activities growth rates for Compugen Ltd have been -63% over the past three years , -46% over the past five years , and -27% over the past ten years .
You don't have any saved screeners yet
